Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
And why it's men especially who need to wake up to the danger
Patrick McIntosh, 58, from Surrey was diagnosed with anaemia 2 years ago
A fortnight later he underwent tests with an endoscope and cameras
He had bowel cancer and had to have 17 inches his colon taken out
Anti-inflammatory agents 'should be added to the mix', say some experts
Standard treatment is surgery, chemotherapy/radiotherapy, and hormones
Some believe that anti-inflammatory drugs should be added to the mix
May help results with treatments like tamoxifen, anastrozole and chemo
... the body's immune system from fighting certain diseases – like cancer. ... cell receptor called TIGIT – a natural body defense to the spread of cancer.
Cancer vaccines turn the body's own immune system specifically against tumor cells and one area of study are vaccines that are directed against ...
New test to predict the effectiveness of cancer vaccines - HealthCanal.com
Proximity Ligation Assay helps detect effectiveness of cancer vaccines - News-Medical.net
National Cancer Institute researchers recently investigated the association ... which help keep the cancer-fighting immune system powers healthy.
Upon further investigation, researchers discovered that cancer cells sometimes ... They prevent the immune system from removing runaway growths.
Cancer cells, however, pay no attention to the rules. ... Since senescent cells may be removed by the immune system, this seems to be a natural ...
During immunotherapy, a patient receives a drug that stimulates his or her immune system, which in turn attacks the cancer that the drug is designed ...
"We are looking forward to the results of this expanded preclinical study of the effectiveness of our pancreatic cancer treatment in reducing the rate of ...
Lowe was concerned about the lack of effective therapies for people with pancreatic cancer and hoped that by finding genes that are active in those ...
In an animal model of human pancreatic cancer, the ADC delivered up to 135-times the amount of SN-38 to the tumor than when irinotecan, the parent ...
Earlier in the week, Reolysin was granted orphan drug status by the FDA for the treatment of pancreatic cancer. Last week, the candidate was granted ...
For liver cancer, the reduction was 24 percent in older patients, and for ... though smaller, improvements in survival for lung and pancreatic cancers.
More cancer patients surviving longer, but age-based disparities remain - Family Practice News Digital Network
He said: '[This] sends out the wrong message, namely that people under 45 years old do not get bladder cancer and therefore do not need referring.
... the liver.1 In contrast, high CD10 expression in bladder cancer predicted a more favorable outcome than those patients with CD10 negative bladder ...
Drinking plenty of water and other liquids may reduce the risk of bladder cancer by diluting the concentration of cancer-causing agents in urine and ...
According to a new study published in the Journal of Clinical Oncology, researchers in the Netherlands have found that although vitiligo-like ...
Riddell, a world-renowned immunotherapy researcher and oncologist at Fred Hutchinson Cancer Research Center, made the comments to the nearly ...
Evidence now in platinum-resistant and recurrent ovarian cancer patients, populations which historically have had little to no response to new ...
This is arguably the hottest field of cancer research today because of the recent groundbreaking successes of cancer immunotherapy in the clinic—the ...
... and his/her team to appreciate the relevant changes in the field,” said Goy, chief of the Division of Lymphoma at John Theurer Cancer Center.
Winter Hematology Meeting Highlighted by Talks on Immunotherapy, Personalized Medicine - Targeted Oncology
Ex vivo isolation and expansion of autologous or allogeneic tumor-reactive T cells, i.e. adoptive T-cell immunotherapy, has been used to treat cancer ...
"As soon as pancreatic cancer develops, it begins to spread, and PKD1 is key to both processes. Given this finding, we are busy developing a PKD1 ...
House immediately sought treatment at Moffitt Cancer Center because they ... For pancreatic cancer cases like Chase's, Moffitt is out-performing the ...
This slideshow reviews drug information for SUTENT (sunitinib), indicated for gastrointestinal stromal tumor, advanced renal cell carcinoma ...
This and other recent findings highlight new opportunities for CD4 T cells in cancer immunotherapy. In this article, I discuss the role and regulation of ...
Immuno-Oncology News
... protein drugs that are invisible to the human immune system,” Dr. Griswold explains in a Dartmouth Hitchcock Norris Cotton Cancer Center release.
Coffee and Cancer Risk
This slide show highlights recent studies that looked into the link between coffee and the risk of hepatocellular carcinoma, melanoma, breast cancer, and more.
This slide show highlights recent studies that looked into the link between coffee and the risk of hepatocellular carcinoma, melanoma, breast cancer, and more.
Medicare Launches Performance-Based Cancer Payment Model
CMS has launched a new multi-payer cancer payment model that reimburses oncologists for episodes of care surrounding chemotherapy treatment, part of a larger effort by the agency to reward physicians based on quality rather than quantity of care.
CMS has launched a new multi-payer cancer payment model that reimburses oncologists for episodes of care surrounding chemotherapy treatment, part of a larger effort by the agency to reward physicians based on quality rather than quantity of care.
FDA Approves Lenvatinib for Thyroid Cancer
The FDA has approved lenvatinib (Lenvima) for the treatment of patients with progressive, differentiated thyroid cancer refractory to radioactive iodine.
The FDA has approved lenvatinib (Lenvima) for the treatment of patients with progressive, differentiated thyroid cancer refractory to radioactive iodine.
Childhood Cancer Survivors at Risk for Hormone Deficiencies After Radiotherapy
A new study finds that childhood cancer survivors are at risk for pituitary hormone deficiencies after radiotherapy treatment to the head.
A new study finds that childhood cancer survivors are at risk for pituitary hormone deficiencies after radiotherapy treatment to the head.
OncoTherapy Network
Prostate Cancer Screening – What Does the Evidence Tell Us?
In May 2012, the United States Preventive Services Task Force (USPSTF) released a recommendation against prostate-specific antigen (PSA) screening for men. The justification for this recommendation was that large randomized trials demonstrated that PSA screening increased detection of prostate cancer, but there was "small to no reduction in prostate cancer-specific mortality."
In May 2012, the United States Preventive Services Task Force (USPSTF) released a recommendation against prostate-specific antigen (PSA) screening for men. The justification for this recommendation was that large randomized trials demonstrated that PSA screening increased detection of prostate cancer, but there was "small to no reduction in prostate cancer-specific mortality."
Sequential TKI May Benefit Advanced Renal Cell Carcinoma Patients
For patients with metastatic clear cell renal cell carcinoma (mccRCC), administering a sequential, second-line tyrosine kinase inhibitor (TKI) may be more beneficial over a mammalian target of rapamycin inhibitor (mTORi).
For patients with metastatic clear cell renal cell carcinoma (mccRCC), administering a sequential, second-line tyrosine kinase inhibitor (TKI) may be more beneficial over a mammalian target of rapamycin inhibitor (mTORi).
Science Daily Cancer News
Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments.
Most women (85 percent) would back the idea of more frequent breast screening if they are at higher genetic risk of developing breast cancer, according to research.
Researchers report on a study in which they determined how well the prospective subjects understood the information presented in leaflets about mammography screening and whether this information influenced their willingness to undergo screening.
A promising new therapeutic target for prostate cancer has been found by researchers, offering evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors promotes prostate cancer cell growth.
Tambahkan Komentar